Tag: kamp

Kamp to Washington Post: Companies Should Be Able to Speak Truthfully About Drugs

CMS Proposes Eliminating CME Sunshine Act Exemption

New FDA Social Media Guidances Address Space-limited Media, Correcting Online Misinformation

AMA House of Delegates: Revise Sunshine Act Rules on Textbook/Reprints and TOV Amount

As Sunshine Act Phase One Implemenation Ends, Compliance Concerns Grow

FTC Calls for Data Broker Legislation To Protect Consumers

OPDP Enforcement Letters Address Omission of Risk Information

WLF: FDA’s Revised Reprint Draft Guidance Violates Injunction and First Amendment

FTC Cites Privacy Concerns Related to Mobile Health Apps